DexCom Backtesting

DXCM -- USA Stock  

USD 125.17  1.91  1.50%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of DexCom and determine expected loss or profit from investing in DexCom over given investment horizon. Additionally see DexCom Hype Analysis, DexCom Correlation, DexCom Valuation, DexCom Volatility as well as analyze DexCom Alpha and Beta and DexCom Performance.
Horizon     30 Days    Login   to change
SymbolX
Backtest

DexCom 'What if' Analysis

September 17, 2018
0.00
No Change 0.00  0.0%
In 31 days
October 17, 2018
0.00
If you would invest  0.00  in DexCom on September 17, 2018 and sell it all today you would earn a total of 0.00 from holding DexCom or generate 0.0% return on investment in DexCom over 30 days. DexCom is related to or competes with Agilent Technologies, Laboratory, DarioHealth Corp, Fluidigm, Fulgent Genetics, and American Renal. DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose ...

DexCom Upside/Downside Indicators

Information Ratio0.13
Maximum Drawdown11.19
Value At Risk3.70
Potential Upside3.82
  

DexCom Market Premium Indicators

Risk Adjusted Performance0.16
Jensen Alpha0.39
Total Risk Alpha0.26
Treynor Ratio1.13

DexCom Backtested Returns

Macroaxis considers DexCom to be not too risky. DexCom secures Sharpe Ratio (or Efficiency) of -0.1482 which denotes DexCom had -0.1482% of return per unit of risk over the last 1 month. Macroaxis philosophy towards predicting risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. DexCom exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm DexCom Coefficient Of Variation of 660.25 and Mean Deviation of 2.04 to check risk estimate we provide. Macroaxis gives DexCom performance score of 0 on a scale of 0 to 100. The firm shows Beta (market volatility) of 0.3664 which denotes to the fact that as returns on market increase, DexCom returns are expected to increase less than the market. However during bear market, the loss on holding DexCom will be expected to be smaller as well.. Even though it is essential to pay attention to DexCom historical returns, it is always good to be careful when utilizing equity current trending patterns. Macroaxis philosophy towards predicting future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. DexCom exposes twenty-one different technical indicators which can help you to evaluate its performance. DexCom has expected return of -0.3882%. Please be advised to confirm DexCom Jensen Alpha, Potential Upside as well as the relationship between Potential Upside and Skewness to decide if DexCom past performance will be repeated at some point in the near future.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.35) 

Poor reverse predictability

DexCom has poor reverse predictability. Overlapping area represents the amount of predictability between DexCom time series from September 17, 2018 to October 2, 2018 and October 2, 2018 to October 17, 2018. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DexCom price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current DexCom price fluctuation can be explain by its past prices. Given that DexCom has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of DexCom for similar time interval.
Correlation Coefficient-0.35
Spearman Rank Test-0.21
Residual Average0.0
Price Variance8.74

DexCom lagged returns against current returns

 Current and Lagged Values 
      Timeline 

DexCom regressed lagged prices vs. current prices

 Current vs Lagged Prices 
      Timeline 

DexCom Lagged Returns

 Regressed Prices 
      Timeline 

Current Sentiment - DXCM

DexCom Investor Sentiment

Most of Macroaxis users are currently bullish on DexCom. What is your opinion about investing in DexCom? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

DexCom Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for DexCom and Agilent Technologies. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see DexCom Hype Analysis, DexCom Correlation, DexCom Valuation, DexCom Volatility as well as analyze DexCom Alpha and Beta and DexCom Performance. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Search macroaxis.com